Signs are growing that Ukrainian forces have penetrated Russian defenses along part of the southern front lines in Zaporizhzhia region and are expanding a wedge toward the strategic town of Tokmak, while stepping up attacks on Russian-occupied Crimea....
KABUL, Afghanistan (AP) — The Taliban have settled in as rulers of Afghanistan, two years after they seized power as U.S. and NATO forces withdrew from the country following two decades of war....
he floating barrier, which is intended to block migrants crossing from Mexico, was installed last month without federal authorization, according to the US Justice Department, which is suing the state of Texas over its use of the buoys....
National police chief: “a police officer should not be in prison, even if he may have committed serious faults or errors in the course of his work.” Left-wing opposition blasted government for failing to rein in “a police hierarchy that places itself above the law”.
LA PAZ, July 28 (Reuters) - Bolivia’s government is determined to curb dependence on the U.S. dollar for foreign trade, instead turning to the Chinese yuan, officials said, as Latin American support for alternative currencies grows....
For all the focus on a potential invasion, some in Taipei fear a Chinese pressure campaign that gradually changes the status quo Alt Link: archive.ph/NuiWR
The Kuki-Zo youth, who was arrested for sharing a post on CM Biren Singh, was being taken from court to jail on May 4, when a mob of around 800 men and women intercepted the police vehicle, dragged him out and beat him to death
French courts have been imposing disproportionately severe sentences for minor offenses, including 10 months in prison for stealing a can of Red Bull and one year for a homeless boy with schizophrenia caught looting a luxury store. The overwhelmed courts rush cases, provide minimal time for defendants, and prioritize punishment...
Japanese drugmaker Eisai and US-based Biogen have been working together on advancing research in the space of Alzheimer’s for nearly a decade. Finally, the FDA, granted the fruits of that labor, Leqembi, its blessing for intravenous use. This marks the first approved treatment that can slow the progression of Alzheimer’s.